Certified Researchers

Gastroscopes Market Summary

As per MRFR analysis, the Gastroscopes Market Size was estimated at 2873.01 USD Million in 2024. The Gastroscopes industry is projected to grow from 3079.93 in 2025 to 6174.06 by 2035, exhibiting a compound annual growth rate (CAGR) of 7.2% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Gastroscopes Market is experiencing robust growth driven by technological advancements and shifting healthcare paradigms.

Technological advancements in gastroscopy are enhancing diagnostic accuracy and patient outcomes.
The market is witnessing a shift towards outpatient procedures, particularly in the Asia-Pacific region, which is the fastest-growing market.
Patient safety and comfort are becoming increasingly prioritized, influencing the design and functionality of gastroscopes.
Rising incidence of gastrointestinal disorders and increasing healthcare expenditure are key drivers propelling market growth.

Market Size & Forecast

2024 Market Size	2873.01 (USD Million)
2035 Market Size	6174.06 (USD Million)
CAGR (2025 - 2035)	7.2%

Major Players

Olympus Corporation (JP), Fujifilm Holdings Corporation (JP), Medtronic plc (IE), Boston Scientific Corporation (US), Pentax Medical (JP), Karl Storz SE & Co. KG (DE), Conmed Corporation (US), Hoya Corporation (JP), Stryker Corporation (US)

Our Impact

Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals

Partnering with 2000+ Global Organizations Each Year

30K+ Citations by Top-Tier Firms in the Industry

Gastroscopes Market Trends

The Gastroscopes Market is currently experiencing a notable transformation, driven by advancements in technology and increasing demand for minimally invasive procedures. The integration of high-definition imaging and flexible designs has enhanced the diagnostic capabilities of gastroscopes, allowing for more accurate assessments of gastrointestinal conditions. Furthermore, the rising prevalence of gastrointestinal disorders is prompting healthcare providers to adopt these innovative devices, thereby expanding their applications in both clinical and outpatient settings. As a result, the Gastroscopes Market is poised for substantial growth, with stakeholders focusing on improving patient outcomes and operational efficiencies.

In addition to technological advancements, the Gastroscopes Market is witnessing a shift towards patient-centered care. Healthcare professionals are increasingly prioritizing the comfort and safety of patients during procedures, which has led to the development of user-friendly gastroscopes. This trend is likely to foster greater patient compliance and satisfaction, ultimately influencing the market dynamics. Moreover, the ongoing research and development efforts aimed at enhancing the functionality and versatility of gastroscopes suggest a promising future for this sector, as it adapts to the evolving needs of healthcare providers and patients alike.

Technological Advancements

The Gastroscopes Market is witnessing rapid technological innovations, particularly in imaging and design. Enhanced visualization capabilities, such as high-definition and narrow-band imaging, are improving diagnostic accuracy. Additionally, the development of flexible and ergonomic designs is facilitating easier handling and patient comfort.

Shift Towards Outpatient Procedures

There is a growing trend towards outpatient procedures within the Gastroscopes Market. This shift is driven by the desire for more efficient healthcare delivery, leading to increased demand for portable and user-friendly gastroscopes that can be utilized in various clinical settings.

Focus on Patient Safety and Comfort

Manufacturers in the Gastroscopes Market are increasingly prioritizing patient safety and comfort. Innovations aimed at reducing discomfort during procedures, along with enhanced safety features, are becoming essential considerations in the design and development of new gastroscopes.

Gastroscopes Market Drivers

Market Growth Projections

The Global Gastroscopes Market Industry is poised for substantial growth, with projections indicating a market value of 2.87 USD Billion in 2024 and an anticipated increase to 6.17 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate of 7.21% from 2025 to 2035, reflecting the increasing adoption of gastroscopy technologies and the rising prevalence of gastrointestinal disorders. The market's expansion is likely to be fueled by technological advancements, growing healthcare expenditure, and an aging population, positioning gastroscopes as essential tools in modern diagnostic practices.

Rising Healthcare Expenditure

Increased healthcare expenditure across various regions is a significant driver for the Global Gastroscopes Market Industry. Governments and private sectors are investing more in healthcare infrastructure, leading to the procurement of advanced medical equipment, including gastroscopes. For instance, countries with robust healthcare systems are allocating substantial budgets to enhance diagnostic capabilities. This investment trend is expected to facilitate the adoption of innovative gastroscopy technologies, thereby expanding the market. As healthcare systems evolve, the demand for effective diagnostic tools like gastroscopes is likely to rise, contributing to the overall market growth.

Technological Advancements in Gastroscopy

Technological innovations are transforming the Global Gastroscopes Market Industry, enhancing the capabilities of gastroscopes. Developments such as high-definition imaging, narrow-band imaging, and capsule endoscopy are improving diagnostic precision and patient comfort. These advancements facilitate earlier detection of gastrointestinal diseases, which is crucial for effective treatment. Moreover, the integration of artificial intelligence in gastroscopy is likely to streamline procedures and reduce human error. As these technologies become more prevalent, they are expected to attract investments, further propelling the market's growth trajectory towards an estimated 6.17 USD Billion by 2035.

Aging Population and Associated Healthcare Needs

The aging population worldwide is a critical factor influencing the Global Gastroscopes Market Industry. As individuals age, they become more susceptible to gastrointestinal disorders, necessitating regular screenings and diagnostic procedures. This demographic shift is particularly pronounced in developed nations, where the proportion of elderly citizens is increasing. Consequently, healthcare providers are focusing on enhancing their diagnostic capabilities to cater to this growing patient population. The demand for gastroscopy services is expected to rise in tandem with the aging demographic, further driving market growth in the coming years.

Growing Demand for Minimally Invasive Procedures

The shift towards minimally invasive procedures is a notable trend influencing the Global Gastroscopes Market Industry. Patients increasingly prefer procedures that minimize recovery time and reduce surgical risks. Gastroscopy, being a minimally invasive diagnostic tool, aligns with this preference, leading to higher adoption rates among healthcare providers. This trend is particularly evident in developed regions where patient awareness and access to advanced medical technologies are higher. As a result, the market is projected to experience a compound annual growth rate of 7.21% from 2025 to 2035, reflecting the growing acceptance of gastroscopy as a preferred diagnostic method.

Increasing Prevalence of Gastrointestinal Disorders

The rising incidence of gastrointestinal disorders globally drives demand within the Global Gastroscopes Market Industry. Conditions such as gastroesophageal reflux disease, peptic ulcers, and colorectal cancer are becoming increasingly common, necessitating effective diagnostic tools. For instance, the World Health Organization indicates that gastrointestinal diseases account for a significant percentage of global morbidity. As a result, healthcare providers are investing in advanced gastroscopy technologies to enhance diagnostic accuracy and patient outcomes. This trend is expected to contribute to the market's growth, with projections estimating the market value to reach 2.87 USD Billion in 2024.

Market Segment Insights

By Application: Diagnostic (Largest) vs. Therapeutic (Fastest-Growing)

The gastroscopes market is segmented primarily into four application areas: Diagnostic, Therapeutic, Surgical, and Screening. The Diagnostic segment currently holds the largest share, as it is widely adopted for various gastrointestinal examinations, making it fundamental to the Gastroscopes Market. Therapeutic applications, while smaller in share, are rapidly gaining traction due to advances in minimally invasive procedures that cater to specific gastrointestinal conditions, highlighting a shift towards proactive treatment strategies.

Application: Diagnostic (Dominant) vs. Therapeutic (Emerging)

In the Gastroscopes Market, the Diagnostic application is considered dominant, characterized by its extensive utilization in medical facilities for routine examinations and accurate diagnosis of gastrointestinal ailments. Its established presence and necessity in clinical settings underscore its significant role. Conversely, the Therapeutic application, while emerging, is gaining momentum due to advancements in technology and an expanding range of treatment options available via gastroscopy. This segment includes procedures that not only diagnose but also treat, such as biopsies and polypectomies. The convergence of diagnostic and therapeutic capabilities within gastroscopes is creating a dynamic market landscape, where innovations are fostering growth and encouraging healthcare providers to adopt these multifunctional instruments, thus fulfilling evolving patient care needs.

By End Use: Hospitals (Largest) vs. Specialty Clinics (Fastest-Growing)

In the Gastroscopes Market, the end use distribution reveals that hospitals occupy the largest share, reflecting their significant demand for advanced diagnostic and therapeutic procedures. The infrastructure and resources available in hospitals facilitate the integration of sophisticated gastroscopy equipment, making them the primary end users. Specialty clinics, while smaller in market share, are rapidly emerging due to their focused services and increasing patient preference for outpatient procedures. The growth trends in this segment are largely driven by technological advancements in gastroscopy, improvements in patient safety, and the rise in gastrointestinal diseases necessitating more efficient diagnostic tools. Ambulatory Surgical Centers (ASCs) are also contributing to growth, as they provide cost-effective options for patients and are gaining popularity due to the convenience of outpatient services. These factors suggest a competitive and evolving landscape in the end-use sector of the market.

Hospitals (Dominant) vs. Specialty Clinics (Emerging)

In the Gastroscopes Market, hospitals are the dominant segment due to their extensive resources, advanced technology, and comprehensive care capabilities. They typically have a higher volume of procedures and better access to a range of gastroscopy devices, ensuring they meet a broader spectrum of medical needs. The presence of specialists in hospitals also supports the continual use of sophisticated devices, further solidifying their position in the market. On the other hand, specialty clinics are emerging as a significant force, catering to specific patient populations with tailored services, such as gastrointestinal health. Their focused approach, lessened operational costs, and patient-centric models are fostering rapid growth, attracting patients who prefer outpatient settings for their procedures.

By Product Type: Flexible Gastroscopes (Largest) vs. Rigid Gastroscopes (Fastest-Growing)

In the Gastroscopes Market, the product type segment showcases a diverse landscape, with flexible gastroscopes asserting dominance due to their versatility and patient comfort. These instruments are widely preferred for various procedures in both outpatient and inpatient settings. Rigid gastroscopes, while holding a smaller market share, are gaining traction in specialized surgical applications where precise visualization is paramount. This distribution indicates a clear preference for flexible models among healthcare providers, influenced by advancements in technology and rising patient expectations. As the market evolves, the growth trends indicate a notable surge in the adoption of rigid gastroscopes, particularly in surgical environments. Factors driving this growth include increasing investments in surgical precision and technology, alongside rising incidence rates of gastrointestinal disorders. The flexibility of design and enhanced imaging capabilities are propelling the advancement of rigid gastroscopes, making them an essential tool for specialists aiming for optimal patient outcomes.

Flexible Gastroscopes (Dominant) vs. Video Gastroscopes (Emerging)

Flexible gastroscopes continue to dominate the market due to their adaptability and superior patient experience, making them the preferred choice for a range of diagnostic and therapeutic procedures. Their ability to navigate through the gastrointestinal tract with minimal discomfort aligns with the evolving standards of patient care. In contrast, video gastroscopes are emerging rapidly, leveraging advancements in imaging technology to provide high-definition video feeds that enhance visualization during procedures. This evolution is pushing video gastroscopes into spotlight, especially as healthcare facilities prioritize accurate diagnostics. The integration of video technology into endoscopic procedures signifies a shift toward more efficient and detailed examinations, providing healthcare professionals with valuable insights while catering to patient-focused approaches.

By Technology: Optical Technology (Largest) vs. Digital Technology (Fastest-Growing)

The technology segment of the gastroscopes market displays a diverse landscape, with optical technology currently holding the largest market share. This traditional technology has been trusted for its reliability and clarity, making it a preferred choice among medical professionals for diagnostic procedures. Digital technology, in contrast, is rapidly gaining prominence as a significant alternative, enabling enhanced imaging and data management capabilities, thereby steadily increasing its share in the market.

Technology: Optical (Dominant) vs. Digital (Emerging)

Optical technology remains the dominant force in the gastroscope market, celebrated for its high-definition imaging that facilitates accurate diagnoses. However, digital technology is emerging as a significant contender, offering advanced features such as real-time data streaming and integration with electronic health records. This shift towards digital solutions highlights the growing demand for efficiency and innovation in medical procedures. While optical technology continues to be favored for its proven track record, digital technology's rapid advancements position it as a compelling option, signaling a transformative phase in gastroscope technology.

By Patient Demographics: Adults (Largest) vs. Geriatrics (Fastest-Growing)

In the Gastroscopes Market, the patient demographics segment is primarily dominated by adults, who represent the largest portion of market share. This significant presence is attributed to the increasing prevalence of gastrointestinal disorders among the adult population, as well as heightened awareness and early diagnosis efforts. While adults remain the largest segment, geriatrics are emerging as a crucial demographic. The aging population is experiencing a rise in GI-related health issues, making geriatric patients a vital focus for market growth and innovation in gastroscope technology.

Patient Demographics: Adults (Dominant) vs. Geriatrics (Emerging)

Adults in the Gastroscopes Market stand as the dominant segment due to their extensive need for gastroenterological evaluations and procedures. This demographic benefits from a broader range of diagnosis and treatment options, positioning them at the forefront of market demand. On the other hand, geriatrics represent an emerging sector, fueled by the increasing aging population. As the elderly are more susceptible to gastrointestinal diseases, the demand for adaptable and advanced gastroscopes tailored to their needs is surging. This shift is promoting innovation in technology, aiming to improve comfort and diagnostic efficacy for geriatric patients.

Get more detailed insights about Gastroscopes Market

Request Free Sample

Regional Insights

North America : Market Leader in Gastroscopes

North America is poised to maintain its leadership in the gastroscopes market, holding a significant share of 1436.5 million in 2024. The region's growth is driven by increasing healthcare expenditure, technological advancements, and a rising prevalence of gastrointestinal disorders. Regulatory support and favorable reimbursement policies further catalyze market expansion, making it a hub for innovation in medical devices. The competitive landscape in North America is robust, featuring key players such as Olympus Corporation, Medtronic, and Boston Scientific. The U.S. stands out as the largest market, supported by a well-established healthcare infrastructure and high demand for minimally invasive procedures. The presence of leading manufacturers ensures a continuous influx of advanced gastroscope technologies, enhancing patient outcomes and driving market growth.

Europe : Emerging Market Dynamics

Europe's gastroscopes market is projected to reach 860.0 million by 2025, driven by an aging population and increasing awareness of gastrointestinal health. Regulatory frameworks, such as the Medical Device Regulation (MDR), are enhancing product safety and efficacy, thereby boosting consumer confidence. The demand for advanced diagnostic tools is also on the rise, contributing to market growth across various European nations. Leading countries in this region include Germany, France, and the UK, where healthcare investments are substantial. The competitive landscape features major players like Karl Storz and Fujifilm, who are innovating to meet the growing demand. The European market is characterized by a mix of established companies and emerging startups, fostering a dynamic environment for technological advancements in gastroscopes.

Asia-Pacific : Rapid Growth Potential

The Asia-Pacific gastroscopes market, valued at 490.0 million, is experiencing rapid growth due to increasing healthcare access and rising awareness of gastrointestinal diseases. The region's expanding middle class and government initiatives to improve healthcare infrastructure are significant growth drivers. Additionally, the demand for minimally invasive procedures is propelling the adoption of advanced gastroscopes, enhancing diagnostic capabilities across the region. Countries like Japan, China, and India are leading the market, with Japan being a key player in technological advancements. The competitive landscape includes major companies such as Olympus and Fujifilm, which are focusing on innovation and expanding their product offerings. The presence of a large patient population and increasing healthcare investments further support the market's growth trajectory.

Middle East and Africa : Emerging Market Opportunities

The Middle East and Africa (MEA) gastroscopes market, valued at 86.51 million, is gradually emerging as a significant player in the global landscape. Factors such as increasing healthcare investments, rising awareness of gastrointestinal health, and a growing population are driving market growth. Regulatory bodies are also beginning to implement frameworks that support the introduction of advanced medical technologies, enhancing market potential. Countries like South Africa and the UAE are at the forefront of this growth, with increasing healthcare facilities and investments in medical technology. The competitive landscape is evolving, with both local and international players entering the market. Companies are focusing on expanding their presence and product offerings to cater to the growing demand for gastroscopes in the region.

Key Players and Competitive Insights

The Gastroscopes Market is characterized by a dynamic competitive landscape, driven by technological advancements, increasing prevalence of gastrointestinal disorders, and a growing emphasis on minimally invasive procedures. Key players such as Olympus Corporation (JP), Fujifilm Holdings Corporation (JP), and Medtronic plc (IE) are at the forefront, each adopting distinct strategies to enhance their market positioning. Olympus Corporation (JP) focuses on innovation in imaging technology, while Fujifilm Holdings Corporation (JP) emphasizes partnerships to expand its product offerings. Medtronic plc (IE) is actively pursuing mergers and acquisitions to bolster its portfolio, indicating a trend towards consolidation in the Gastroscopes Market. Collectively, these strategies contribute to a competitive environment that is increasingly centered on technological differentiation and strategic collaborations.
In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for niche players to thrive, while larger corporations leverage their resources to capture significant market share. The collective influence of these key players shapes the market dynamics, fostering an environment where innovation and strategic partnerships are paramount.
In November 2025, Olympus Corporation (JP) announced the launch of its latest endoscopic imaging system, which integrates advanced AI capabilities to enhance diagnostic accuracy. This strategic move underscores Olympus's commitment to innovation and positions the company to meet the growing demand for precise and efficient diagnostic tools in gastroenterology. The integration of AI not only improves patient outcomes but also streamlines clinical workflows, potentially setting a new standard in the industry.
In October 2025, Fujifilm Holdings Corporation (JP) entered into a strategic partnership with a leading healthcare provider to co-develop next-generation gastroscopes. This collaboration aims to leverage Fujifilm's imaging technology and the healthcare provider's clinical expertise, indicating a trend towards collaborative innovation. Such partnerships are likely to accelerate the development of advanced medical devices, enhancing the competitive landscape by introducing cutting-edge solutions to the Gastroscopes Market.
In September 2025, Medtronic plc (IE) completed the acquisition of a prominent endoscopy company, significantly expanding its product portfolio and market reach. This acquisition reflects Medtronic's strategy to consolidate its position in the gastroscope segment and enhance its capabilities in delivering comprehensive gastrointestinal solutions. The move is expected to provide Medtronic with a competitive edge, allowing it to offer a broader range of products and services to healthcare providers.
As of December 2025, the competitive trends in the Gastroscopes Market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are shaping the landscape, fostering innovation and enhancing product offerings. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident. Companies that prioritize innovation and strategic partnerships are likely to differentiate themselves in this evolving market, positioning themselves for sustained growth and success.

Key Companies in the Gastroscopes Market include

Industry Developments

November 2022:The launch of PENTAX Medical's new Performance Endoscopic Ultrasound (EUS) system, which combines the brand-new ARIETTA 65 PX ultrasound scanner with their best-in-class J10 Series Ultrasound Gastroscopes Market. PENTAX Medical is a leader in the healthcare industry for diagnostic and therapeutic gastroscopy solutions.

April 2020:Olympus launched of EVIS X1, the most cutting-edge gastroscopic systems. The debut of EVIS X1, the company's most innovative gastroscopic system to date, was announced by Olympus Corporation. The new approach will boost outcomes from bronchial diseases, stomach, and oesophageal disorders by giving every gastroscopis cutting-edge equipment.

Future Outlook

Gastroscopes Market Future Outlook

The Gastroscopes is projected to grow at a 7.2% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of gastrointestinal disorders, and rising healthcare expenditure.

New opportunities lie in:

Development of AI-integrated gastroscopes for enhanced diagnostic accuracy. Expansion of telemedicine services for remote gastroscopy consultations. Investment in disposable gastroscope technology to reduce infection risks.

By 2035, the gastroscopes market is expected to achieve substantial growth, driven by innovation and increased demand. The gastroscopes market analysis shows that technological evolution helps in market growth.

Market Segmentation

Gastroscopes Market End Use Outlook

Hospitals
Ambulatory Surgical Centers
Specialty Clinics

Gastroscopes Market Technology Outlook

Optical Technology
Digital Technology
Wireless Technology

Gastroscopes Market Application Outlook

Diagnostic
Therapeutic
Surgical
Screening

Gastroscopes Market Product Type Outlook

Flexible Gastroscopes
Rigid Gastroscopes
Video Gastroscopes

Report Scope

MARKET SIZE 2024	2873.01(USD Million)
MARKET SIZE 2025	3079.93(USD Million)
MARKET SIZE 2035	6174.06(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	7.2% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Million
Key Companies Profiled	Olympus Corporation (JP), Fujifilm Holdings Corporation (JP), Medtronic plc (IE), Boston Scientific Corporation (US), Pentax Medical (JP), Karl Storz SE & Co. KG (DE), Conmed Corporation (US), Hoya Corporation (JP), Stryker Corporation (US)
Segments Covered	Application, End Use, Product Type, Technology
Key Market Opportunities	Integration of advanced imaging technologies enhances diagnostic capabilities in the Gastroscopes Market.
Key Market Dynamics	Technological advancements and regulatory changes drive innovation and competition in the gastroscopes market.
Countries Covered	North America, Europe, APAC, South America, MEA

Market Highlights

Gastroscopes Companies

FAQs

What is the current valuation of the Gastroscopes Market as of 2024?

The Gastroscopes Market was valued at approximately 2873.01 USD Million in 2024.

What is the projected market size for the Gastroscopes Market in 2035?

The market is expected to reach a valuation of around 6174.06 USD Million by 2035.

What is the expected CAGR for the Gastroscopes Market during the forecast period 2025 - 2035?

The anticipated CAGR for the Gastroscopes Market during the forecast period is 7.2%.

Which companies are considered key players in the Gastroscopes Market?

Key players in the market include Olympus Corporation, Fujifilm Holdings Corporation, and Medtronic plc, among others.

What are the primary applications of gastroscopes in the market?

The primary applications include Diagnostic, Therapeutic, Surgical, and Screening, with valuations ranging from 573.01 to 2000.0 USD Million.

How does the market segment by end use look in terms of valuation?

The end-use segments include Hospitals, Ambulatory Surgical Centers, and Specialty Clinics, with valuations from 800.0 to 2500.0 USD Million.

What types of gastroscopes are available in the market?

The market features Flexible, Rigid, and Video Gastroscopes, with valuations between 800.0 and 2500.0 USD Million.

What technologies are driving the Gastroscopes Market?

The market is driven by Optical, Digital, and Wireless Technologies, with valuations ranging from 800.0 to 2500.0 USD Million.

How does the Gastroscopes Market segment by patient demographics?

The market segments by patient demographics include Adults, Pediatrics, and Geriatrics, with valuations from 574.2 to 3090.0 USD Million.

What trends are influencing the growth of the Gastroscopes Market?

Trends such as technological advancements and increasing demand for minimally invasive procedures are likely to influence market growth.

Author

Author

Vikita Thakur

Senior Research Analyst

She holds an experience of about 5+ years in market research and business consulting projects for sectors such as life sciences, medical devices, and healthcare IT. She possesses a robust background in data analysis, market estimation, competitive intelligence, pipeline analysis market trend identification, and consumer behavior insights. Her expertise lies in technical Sales support, client interaction and project management, designing and implementing market research studies, conducting competitive analysis, and synthesizing complex data into actionable recommendations that drive business growth.

Co-Author

Rahul Gotadki

Research Manager

He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Get In Touch

Leave a Comment

Certified Researchers

Customize Report

Research Approach

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed medical journals, clinical publications, and authoritative health organizations. Key sources included the US Food & Drug Administration (FDA) medical device database, European Medicines Agency (EMA) medical device regulations, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK/NIH), Centers for Disease Control and Prevention (CDC) digestive disease statistics, World Health Organization (WHO) Global Health Observatory gastrointestinal disease burden data, American Society for Gastrointestinal Endoscopy (ASGE), European Society of Gastrointestinal Endoscopy (ESGE), Japan Gastroenterological Endoscopy Society (JGES), National Health Service (NHS) England endoscopy statistics, Centers for Medicare & Medicaid Services (CMS) procedure utilization data, EU Eurostat Healthcare Database, Organization for Economic Co-operation and Development (OECD) Health Statistics, and national ministry of health reports from key markets (China NHC, Japan MHLW, India Ministry of Health).

These sources were employed to gather endoscopy procedure statistics, 510(k) and PMA approval data, clinical safety studies, reimbursement codes, epidemiological trends for gastric ulcers and chronic gastritis, and market landscape analysis for standard gastroscopes, transnasal gastroscopes, therapeutic gastroscopes, and dual-channel gastroscope technologies.

Primary Research

Qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders during the primary research process. The supply-side sources consisted of CEOs, VPs of Medical Device R&D, regulatory affairs chiefs, and commercial directors from gastroscope manufacturers such as Olympus Corporation, Fujifilm Holdings, Boston Scientific Corporation, Pentax Medical, Karl Storz GmbH, and SonoScape Medical. The demand-side sources consists of board-certified gastroenterologists, endoscopy unit directors, hospital procurement managers, and operations leaders from hospitals, ambulatory surgical centers (ASCs), and specialized endoscopy clinics. The primary research validated market segmentation across device types (standard, transnasal, therapeutic, dual-channel), confirmed product development pipelines, and gathered insights on clinical adoption patterns, capital equipment purchasing cycles, service contract structures, and reimbursement dynamics for upper GI endoscopy procedures.

Primary Respondent Breakdown:

By Designation Level: C-suite Executives (32%), Director Level (30%), Others (38%)

[Others include Department Heads, Senior Managers, and Technical Leads]

By Geographic Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)

Market Size Estimation

Revenue mapping and procedure volume analysis were implemented to determine global market valuation. The methodology comprised the following:

Identification of over 50 main manufacturers in North America, Europe, Asia-Pacific, and Latin America, including dominant players (Olympus, Fujifilm, Pentax) that account for approximately 75% of the market.

Product mapping for standard gastroscopes, transnasal gastroscopes, therapeutic gastroscopes, and dual-channel gastroscopes

Examination of the annual revenues that have been reported and modeled for endoscopy systems and gastroscope portfolios

Manufacturers that account for 70-75% of the global market share in 2024 are included in the coverage.

Derive segment-specific valuations for hospital, diagnostic lab, and ambulatory surgical center end-users through extrapolation using bottom-up (country-level endoscopy procedure volume × average selling price by device type) and top-down (manufacturer revenue validation) approaches.